Stock & Company Details
Cue Biopharma Inc $CUE
Price:
46,691,331
4.2M
$133M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.65
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CUE technical indicators
Latest Cue Biopharma Inc (CUE) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
61.27 2.9%
MACD:
1.60 18.9%
SMA 50:
$23.69 2.7%
SMA 200:
$6.28 2.5%
EMA 20:
$26.99 1.8%
Bollinger Bands:
32.06 / 23.45
Stochastic:
55.63 38.7%
ADX 14:
35.33 3.5%
ATR 14:
3.86 1.5%
CCI 20:
203.05 168.7%
OBV:
408.55M 0.1%
ROC 12:
16.50% 78.9%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.
Finance Bot
Ask your questions
Start by typing a question below.
